These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 290351)

  • 1. Development of resistance to amphotericin B in Candida lusitaniae infecting a human.
    Pappagianis D; Collins MS; Hector R; Remington J
    Antimicrob Agents Chemother; 1979 Aug; 16(2):123-6. PubMed ID: 290351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe pulmonary candidiasis during acute leukosis treated with amphotericin-B; clinical case].
    Sanguinetti M; Maresta A
    G Clin Med; 1968 Mar; 49(3):256-73. PubMed ID: 5266252
    [No Abstract]   [Full Text] [Related]  

  • 3. Amphotericin B: emergency challenge in a neutropenic, asthmatic patient with fungal sepsis.
    Kemp SF; Lockey RF
    J Allergy Clin Immunol; 1995 Sep; 96(3):425-7. PubMed ID: 7560647
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antimycotic prophylaxis with oral amphotericin B in patients with acute myeloid leukemia].
    Orlandi E; Bernasconi C; Michelone G; Cavanna C; Lombardi G
    Clin Ter; 1986 Sep; 118(6):427-31. PubMed ID: 3465492
    [No Abstract]   [Full Text] [Related]  

  • 5. Bilateral Candida endophthalmitis accompanying Candida lusitaniae bloodstream infection: A case report.
    Yamamoto S; Ikeda M; Fujimoto F; Okamoto K; Wakabayashi Y; Sato T; Tatsuno K; Kaburaki T; Yoshida S; Okugawa S; Koike K; Moriya K
    J Infect Chemother; 2018 Feb; 24(2):147-149. PubMed ID: 29102349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance.
    McClenny NB; Fei H; Baron EJ; Gales AC; Houston A; Hollis RJ; Pfaller MA
    Antimicrob Agents Chemother; 2002 May; 46(5):1325-8. PubMed ID: 11959563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical microbiological case: chronic disseminated candidiasis unresponsive to treatment.
    Ratip S; Odabaşi Z; Karti S; Cetiner M; Yeğen C; Cerikcioğlu N; Bayik M; Korten V;
    Clin Microbiol Infect; 2002 Jul; 8(7):435-6, 442-4. PubMed ID: 12199855
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae.
    Guinet R; Chanas J; Goullier A; Bonnefoy G; Ambroise-Thomas P
    J Clin Microbiol; 1983 Aug; 18(2):443-4. PubMed ID: 6619295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida lusitaniae catheter-related sepsis.
    Pietrucha-Dilanchian P; Lewis RE; Ahmad H; Lechin AE
    Ann Pharmacother; 2001 Dec; 35(12):1570-4. PubMed ID: 11793623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
    Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersplenism due to disseminated candidiasis in a patient with acute leukemia.
    Bodey GP; DeJongh D; Isassi A; Freireich EJ
    Cancer; 1969 Aug; 24(2):417-20. PubMed ID: 5256261
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.
    Asner SA; Giulieri S; Diezi M; Marchetti O; Sanglard D
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7715-22. PubMed ID: 26438490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertebral disc space infection and osteomyelitis due to Candida albicans in a patient with acute myelomonocytic leukemia.
    Shaikh BS; Appelbaum PC; Aber RC
    Cancer; 1980 Mar; 45(5):1025-8. PubMed ID: 6942903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatosplenic candidiasis in patients with acute leukemia: what is the optimum prophylaxis following subsequent chemotherapy.
    Dear A
    Eur J Haematol; 1994 Mar; 52(3):184-6. PubMed ID: 8168600
    [No Abstract]   [Full Text] [Related]  

  • 15. Candida lusitaniae infections in the era of fluconazole availability.
    Hawkins JL; Baddour LM
    Clin Infect Dis; 2003 Jan; 36(2):e14-8. PubMed ID: 12522762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice.
    Karyotakis NC; Anaissie EJ
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2660-2. PubMed ID: 7872764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized papules in a patient with acute myeloid leukemia.
    Nakahigashi K; Tanioka M; Miyachi Y
    Arch Dermatol; 2007 Dec; 143(12):1583-8. PubMed ID: 18087015
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient.
    Chemaly RF; Fox SB; Alkotob LM; Scharpf J; Sobecks R; Eliachar I; Procop GW; Smith M; Avery RK; Schmitt SK
    Scand J Infect Dis; 2002; 34(2):149-51. PubMed ID: 11928855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B encapsulated in liposomes administered to cancer patients.
    Meunier F; Sculier JP; Coune A; Brassinne C; Heyman C; Laduron C; Collette N; Hollaert C; Bron D; Klastersky J
    Ann N Y Acad Sci; 1988; 544():598-610. PubMed ID: 2850759
    [No Abstract]   [Full Text] [Related]  

  • 20. Candida arthritis treated with amphotericin B.
    Poplack DG; Jacobs SA
    J Pediatr; 1975 Dec; 87(6 Pt 1):989-90. PubMed ID: 1059760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.